TABLE 2 Primary Non-Hodgkin’s Lymphoma of the Ovary from the Literatureab (n = 19)

From: Ovarian Non-Hodgkin’s Lymphoma: A Clinicopathologic Study of Eight Primary Cases

Reference

Age (y)

Presentation

Ann Arbor Stage

Laterality

Size (cm)

Diagnosis

Immunophenotype

Therapy

Follow-Up

Barzilay et al., 1984 (17)

16

Abdominal pain

IE

B

15, each

“Lymphoblastic” lymphoma

ND

BSO, CT, RT

NED, 9 y

Piura et al., 1986 (18)

16

Abdominal pain

IE

B

15, each

B-LBLc

B-cell

BSO, CT, RT

NED, > 10 y

Seiffer et al., 1986 (19)

24

Incidental finding

IE

R

Microscopic finding in MCT

DLCL

ND

R oophorectomy

Lost to follow-up

Linden et al., 1988 (20)

24

Abdominal pain

IIE

R

14.5

Burkitt lymphomac

B-cell

RSO, CT

NS

 

63

Dyspnea

IIE

L

5

Burkitt lymphomac

B-cell

BSO, CT

NS

Iaffaioli et al., 1990 (21)

40

Abdominal mass

IE

B

L-20, R-8

DLCL

ND

TAH-BSO, CT

NED, 0.4 y

Liang et al., 1990 (22)

38

Abdominal pain

IE

NS

NS

Burkitt lymphomac

B-cell

CT

Alive, 0.8 y

Mittal et al., 1992 (23)

31

Secondary amennorhea

IIE

R

14

Follicular lymphoma, Grade 3c

B-cell

RSO, CT

NED, 0.5 y

Nathwani et al., 1992 (24)

74

Pelvic pain

IIE

R

NS

MZBCLc

B-cell

RSO, CT

NED, 1 y

Monterroso et al., 1993 (2)

6

Abdominal mass

IIE

NS

NS

Burkitt lymphomac

B-cell

NS

Lost to follow-up

 

16

Incidental finding

IE

L

8

DLBCLc

B-cell

BSO, CT, RT

NED, 8.8 y

 

34

Incidental finding

IE

L

3.5

DLBCLc

B-cell

TAH-BSO, CT

NED, 1.3 y

 

55

Incidental finding

IE

L

6

DLBCLc

B-cell

LSO, CT

NED, 4 y

 

62

Incidental finding

IE

L

5

DLBCLc

B-cell

TAH-BSO, CT

DWD, 4.5 y

 

NS

Abdominal mass

IIE

R

NS

Burkitt lymphomac

B-cell

NS

Lost to follow-up

Skodras et al., 1994 (25)

31

Abdominal pain

IE

R

Microscopic finding in SBT

DLCL

ND

TAH-BSO, CT

NED, 0.4 mo

Granovsky-Grisaru et al., 1995 (26)

63

Back pain

IE

L

4

DLBCL

B-cell

TAH-BSO

NED, 5 y

Mitra, 1996 (27)

23

Abdominal pain

IE

R

6

Burkitt lymphoma

ND

RSO

NED, 0.5 y

Dao, 1998 (28)

20

Incidental finding

IE

L

14

DLBCL

B-cell

LSO, CT

NED, 2.5 y

  1. aSee Table 1 for other abbreviations.
  2. bData from Monterroso et al. (2) modified from original publication so that cases are now designated as primary according to our criteria: Ann Arbor stages IE/IIE and IIIE/IV shall correspond to “primary” and “secondary,” respectively.
  3. cTranslated into WHO classification—all others were translated into Working Formulation if using older terminology.
  4. B, bilateral; B-LBL, precursor B-lymphoblastic lymphoma; DLCL, diffuse large cell lymphoma; DWD, dead with disease; LSO, left salpingo-oophorectomy; MCT, mature cystic teratoma; MZBCL, marginal zone B-cell lymphoma; NS, not stated; RSO, right salpingo-oophorectomy; SBT, serous borderline tumor.